10 Menopause & Hormone Therapy Myths: What Women Should Really Know
Updated: Oct 9
For years, women approaching menopause were often told that symptoms were simply something they had to tolerate. At the same time, conflicting information about hormone therapy left many women unsure about what was safe, what was effective, and even what symptoms could be related to menopause.
Fortunately, our understanding of menopause and menopausal hormone therapy (MHT), often called hormone replacement therapy or HRT, has continued to evolve.
Hormone therapy is not appropriate for every woman, nor is it a treatment for every symptom associated with aging. But for appropriately selected patients, it can be a highly effective treatment for certain menopause-related symptoms.
Let us separate some of the most common menopause and hormone therapy myths from what the evidence actually tells us.
Myth #1: Hormone therapy causes breast cancer
Truth: The relationship between hormone therapy and breast cancer is more complicated than that
Much of the fear surrounding hormone therapy began after the initial results of the Women's Health Initiative (WHI) were published in 2002. The findings received enormous media attention and led many women and healthcare providers to abandon hormone therapy.
However, hormone therapy is not one single medication or regimen. Risk varies according to factors including a woman's age, medical history, the type of hormone therapy used, whether estrogen is used alone or with a progestogen, and duration of treatment.
Current menopause guidance emphasizes individualized risk assessment rather than assuming that hormone therapy carries the same risk for every woman.
For most healthy, symptomatic women younger than 60 or within 10 years of menopause onset who do not have contraindications, The Menopause Society considers the overall benefit-risk ratio of hormone therapy favorable.
The important question is not simply, "Is HRT safe?" It is, "What are the potential benefits and risks of HRT for this particular woman?"
Myth #2: You must be completely through menopause before starting hormone therapy
Truth: Hormone therapy may be used during perimenopause
Menopause technically refers to the point when a woman has gone 12 consecutive months without a menstrual period, assuming there is no other explanation. But symptoms can begin years before that happens.
During perimenopause, ovarian hormone production becomes increasingly variable. Women may experience hot flashes, night sweats, sleep disruption, changes in menstrual cycles, vaginal symptoms, and other concerns while they are still having periods.
Treatment does not necessarily need to wait until menstruation has completely stopped. The appropriate treatment depends on symptoms, menstrual patterns, medical history, pregnancy risk, and individual goals.
Myth 3: If my hormone blood tests are normal my symptoms cannot be from perimenopause
Truth: Hormone levels can fluctuate substantially during the menopause transition
One of the most frustrating experiences for women is being told that their laboratory results are normal even though they are experiencing significant symptoms.
During perimenopause, hormones such as estradiol and FSH can fluctuate considerably. A blood test represents hormone levels at one moment in time and may not reflect what has been happening throughout the month.
For women in the typical age range with characteristic symptoms and menstrual changes, the diagnosis of perimenopause is often based primarily on the clinical picture rather than repeatedly checking hormone levels.
Laboratory testing can still be valuable when the diagnosis is uncertain or when another medical condition may be contributing to symptoms.
Myth #4: HRT is only for hot flashes
Truth: Hormone therapy has several established uses in menopause care
Hot flashes and night sweats are among the best-known symptoms of menopause, and systemic hormone therapy remains the most effective treatment for bothersome vasomotor symptoms.
Hormone therapy also has an important role in treating genitourinary syndrome of menopause (GSM), which can include vaginal dryness, burning, discomfort with intercourse, and some urinary symptoms. Systemic hormone therapy also prevents bone loss and reduces fracture risk while it is being used.
That does not mean HRT should be prescribed for every change that occurs around menopause. Current evidence does not support using systemic hormone therapy solely to prevent aging, dementia, cardiovascular disease, weight gain, hair loss, or other primarily age-related changes. Treatment should have a clear indication and should be individualized to the patient.
Myth #5: Bioidentical hormones are different from prescription hormones
Truth: FDA-approved bioidentical hormones already exist
The word bioidentical is often associated with compounded hormone therapy, but the terms are not synonymous. Bioidentical simply means that the hormone has the same molecular structure as the hormone produced by the human body.
FDA-approved 17 beta-estradiol and micronized progesterone are examples of bioidentical hormones. These are available in standardized prescription products that have undergone FDA review for potency, quality, safety, and effectiveness.
Therefore, a woman does not have to use compounded hormone therapy to receive bioidentical hormones.
Myth #6: Compounded hormones are safer because they are more natural
Truth: Compounded hormone therapy has a role in selected circumstances but has not been shown to be safer than FDA-approved hormone therapy
Compounding can be valuable when a patient requires a formulation, dose, or ingredient combination that is not commercially available, for example because of an allergy to an ingredient in an FDA-approved product.
However, compounded hormone products do not undergo the same FDA approval process as commercially manufactured medications.
Professional organizations, including the American College of Obstetricians and Gynecologists (ACOG), recommend FDA-approved menopausal hormone therapies over routinely prescribed compounded preparations when an appropriate FDA-approved option is available. Natural should not automatically be interpreted as meaning safer.
Myth #7: Everyone should stop hormone therapy at age 65
Truth: There is no universal age at which every woman must discontinue hormone therapy
Women were once frequently advised to stop HRT automatically at a certain age. Current guidance is more individualized.
Some women continue to experience significant vasomotor symptoms beyond age 60 or 65. The Menopause Society states that hormone therapy does not need to be routinely discontinued solely because a woman reaches age 60 or 65.
However, age matters. Starting systemic hormone therapy for the first time at an older age or many years after menopause is a different clinical situation from continuing therapy that was started earlier. Cardiovascular, thromboembolic, breast, and other health risks should be periodically reassessed.
For women who continue HRT later in life, the decision should be individualized through shared decision-making with their healthcare provider.
Myth #8: Vaginal estrogen carries the same risks as systemic HRT
Truth: Low-dose vaginal estrogen is different from systemic estrogen therapy
When estrogen is prescribed specifically for vaginal or urinary symptoms of menopause, low-dose vaginal estrogen can deliver estrogen primarily to local tissues with substantially lower systemic exposure than systemic hormone therapy.
For women who primarily experience vaginal dryness, burning, discomfort with intercourse, or other symptoms of GSM, local treatment may be appropriate without the need for systemic hormone therapy.
This distinction is important because the benefits, systemic exposure, and risk considerations are different from those associated with systemic estrogen. Women with a history of estrogen-sensitive cancer or other significant medical conditions should discuss treatment with the clinicians involved in their care.
Myth #9: Menopause automatically makes you gain weight
Truth Menopause is only one part of a much bigger picture
Many women notice that their body composition changes during midlife, particularly an increase in abdominal fat. But it is not accurate to blame every pound gained during this period solely on estrogen deficiency.
Aging, declining muscle mass, physical activity, nutrition, sleep, genetics, and hormonal changes can all contribute to changes in body composition. Hormone therapy should not be prescribed as a weight-loss treatment.
Instead, maintaining muscle through resistance training, consuming adequate nutrition and protein, staying physically active, getting sufficient sleep, and addressing metabolic risk factors are important components of healthy aging.
Myth #10: Menopause symptoms are something women simply must live with
Truth: Effective treatments are available and HRT is only one of them
Menopause is a normal biological transition, but that does not mean women need to suffer through symptoms that significantly interfere with sleep, sexual health, work, relationships, or quality of life.
For some women, hormone therapy is an appropriate and highly effective option. For others, nonhormonal prescription medications, vaginal therapies, lifestyle interventions, or other evidence-based treatments may be more appropriate.
The goal of menopause care is not to give every woman hormones. It is to listen to her symptoms, understand her medical history and goals, discuss the available evidence, and develop an individualized treatment plan.
The Bottom Line
Menopause care has changed considerably over the past several decades, but many outdated ideas about hormone therapy remain.
HRT is neither something every woman needs nor something every woman should fear.
The decision to use hormone therapy should take into account symptoms, age, time since menopause, personal and family medical history, individual risk factors, treatment preferences, and the type, dose, and route of hormone therapy being considered.
Most importantly, women deserve accurate information so they can make informed decisions about their health. If menopause or perimenopause symptoms are affecting your quality of life, talk with a healthcare provider experienced in menopause care about which treatment options may be appropriate for you.
References
Medical Disclaimer: This information is intended for educational purposes only and is not a substitute for individualized medical advice. The benefits and risks of hormone therapy vary among individuals. Treatment decisions should be made in consultation with a qualified healthcare professional.
